Article Details

ReAlta Life Sciences Doses First Subject in Phase 1 Healthy Volunteers Study of RLS-0071

Retrieved on: 2021-02-16 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

ReAlta Life Sciences Doses First Subject in Phase 1 Healthy Volunteers Study of RLS-0071. View article details on hiswai:

Excerpt

... encephalopathy in newborns and hemolytic transfusion reactions. ... biotech company dedicated to harnessing the power of the immune system ...

Article found on: www.argus-press.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up